0
Skip to Content
Health Business Group
Growth Strategy
Due Diligence for Transactions
Tech-enabled Healthcare Services
Life Sciences
Digital Health and AI
Private Equity/Investors
Case Studies
Consultants
History
Testimonials
Podcast
Press
Contact
Health Business Group
Growth Strategy
Due Diligence for Transactions
Tech-enabled Healthcare Services
Life Sciences
Digital Health and AI
Private Equity/Investors
Case Studies
Consultants
History
Testimonials
Podcast
Press
Contact
Folder: Services▾
Back
Growth Strategy
Due Diligence for Transactions
Folder: Sectors ▾
Back
Tech-enabled Healthcare Services
Life Sciences
Digital Health and AI
Private Equity/Investors
Case Studies
Folder: About ▾
Back
Consultants
History
Testimonials
Podcast
Press
Contact
Economics, Health plans, International, Pharma, Podcast, Policy and politics, Research 11/12/20 Economics, Health plans, International, Pharma, Podcast, Policy and politics, Research 11/12/20

ICER founder Dr. Steve Pearson explains COVID-19 remdesivir pricing model

Drug pricing is the hottest topic in healthcare, and ICER founder Dr. Steve Pearson is the coolest person to discuss it with.

Read More
Pharma, Policy and politics 9/14/20 Pharma, Policy and politics 9/14/20

Why does Trump want foreign countries to set Medicare drug prices?

Read More

SERVICES

Growth StrategyDue Diligence for Transactions

SECTORS

Tech-enabled Healthcare Services
Life Sciences

Digital Health and AI
Private Equity/Investors

ABOUT

Consultants
Case Studies
History
Testimonials

Press
Contact

101 Federal St., S. 1900 | Boston, MA 02110 | (617) 731-3182

© 2026 Health Business Group. All Rights Reserved.
Icons by Icon8